Literature DB >> 27402779

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Augustine Goba1, S Humarr Khan1, Mbalu Fonnie1, Mohamed Fullah1, Alex Moigboi1, Alice Kovoma1, Vandi Sinnah1, Nancy Yoko1, Hawa Rogers1, Siddiki Safai1, Mambu Momoh1, Veronica Koroma1, Fatima K Kamara1, Edwin Konowu1, Mohamed Yillah1, Issa French1, Ibraham Mustapha1, Franklyn Kanneh1, Momoh Foday1, Helena McCarthy1, Tiangay Kallon1, Mustupha Kallon1, Jenneh Naiebu1, Josephine Sellu1, Abdul A Jalloh1, Michael Gbakie1, Lansana Kanneh1, James L B Massaly2, David Kargbo2, Brima Kargbo2, Mohamed Vandi2, Momoh Gbetuwa2, Sahr M Gevao3, John D Sandi1, Simbirie C Jalloh1, Donald S Grant4, Sylvia O Blyden5, Ian Crozier6, John S Schieffelin7, Susan L McLellan8, Shevin T Jacob9, Matt L Boisen10, Jessica N Hartnett11, Robert W Cross12, Luis M Branco13, Kristian G Andersen14, Nathan L Yozwiak15, Stephen K Gire16, Ridhi Tariyal16, Daniel J Park15, Allyson M Haislip11, Christopher M Bishop11, Lilia I Melnik11, William R Gallaher17, William C Wimley18, Jing He18, Jeffrey G Shaffer19, Brian M Sullivan20, Sonia Grillo21, Scott Oman22, Courtney E Garry23, Donna R Edwards24, Stephanie J McCormick25, Deborah H Elliott7, Julie A Rouelle7, Chandrika B Kannadka7, Ashley A Reyna7, Benjamin T Bradley7, Haini Yu7, Rachael E Yenni11, Kathryn M Hastie20, Joan B Geisbert12, Peter C Kulakosky25, Russell B Wilson25, Michael B A Oldstone20, Kelly R Pitts26, Lee A Henderson27, James E Robinson7, Thomas W Geisbert12, Erica Ollmann Saphire28, Christian T Happi29, Danny A Asogun30, Pardis C Sabeti31, Robert F Garry32.   

Abstract

BACKGROUND: Kenema Government Hospital (KGH) has developed an advanced clinical and laboratory research capacity to manage the threat of Lassa fever, a viral hemorrhagic fever (VHF). The 2013-2016 Ebola virus (EBOV) disease (EVD) outbreak is the first to have occurred in an area close to a facility with established clinical and laboratory capacity for study of VHFs.
METHODS: Because of its proximity to the epicenter of the EVD outbreak, which began in Guinea in March 2014, the KGH Lassa fever Team mobilized to establish EBOV surveillance and diagnostic capabilities.
RESULTS: Augustine Goba, director of the KGH Lassa laboratory, diagnosed the first documented case of EVD in Sierra Leone, on 25 May 2014. Thereafter, KGH received and cared for numbers of patients with EVD that quickly overwhelmed the capacity for safe management. Numerous healthcare workers contracted and lost their lives to EVD. The vast majority of subsequent EVD cases in West Africa can be traced back to a single transmission chain that includes this first diagnosed case.
CONCLUSIONS: Responding to the challenges of confronting 2 hemorrhagic fever viruses will require continued investments in the development of countermeasures (vaccines, therapeutic agents, and diagnostic assays), infrastructure, and human resources.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus; Lassa virus; West African Ebola outbreak 2013–16; epidemiology; genomic sequencing; research capacity building; viral hemorrhagic fever diagnostics

Mesh:

Year:  2016        PMID: 27402779      PMCID: PMC5050470          DOI: 10.1093/infdis/jiw239

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Persistent Ebola Virus in the Eye.

Authors:  Steven Yeh; Jay B Varkey; Ian Crozier
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

2.  Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.

Authors:  Kristian G Andersen; B Jesse Shapiro; Christian B Matranga; Rachel Sealfon; Aaron E Lin; Lina M Moses; Onikepe A Folarin; Augustine Goba; Ikponmwonsa Odia; Philomena E Ehiane; Mambu Momoh; Eleina M England; Sarah Winnicki; Luis M Branco; Stephen K Gire; Eric Phelan; Ridhi Tariyal; Ryan Tewhey; Omowunmi Omoniwa; Mohammed Fullah; Richard Fonnie; Mbalu Fonnie; Lansana Kanneh; Simbirie Jalloh; Michael Gbakie; Sidiki Saffa; Kandeh Karbo; Adrianne D Gladden; James Qu; Matthew Stremlau; Mahan Nekoui; Hilary K Finucane; Shervin Tabrizi; Joseph J Vitti; Bruce Birren; Michael Fitzgerald; Caryn McCowan; Andrea Ireland; Aaron M Berlin; James Bochicchio; Barbara Tazon-Vega; Niall J Lennon; Elizabeth M Ryan; Zach Bjornson; Danny A Milner; Amanda K Lukens; Nisha Broodie; Megan Rowland; Megan Heinrich; Marjan Akdag; John S Schieffelin; Danielle Levy; Henry Akpan; Daniel G Bausch; Kathleen Rubins; Joseph B McCormick; Eric S Lander; Stephan Günther; Lisa Hensley; Sylvanus Okogbenin; Stephen F Schaffner; Peter O Okokhere; S Humarr Khan; Donald S Grant; George O Akpede; Danny A Asogun; Andreas Gnirke; Joshua Z Levin; Christian T Happi; Robert F Garry; Pardis C Sabeti
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

3.  Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene.

Authors:  Hirohito Ogawa; Hiroko Miyamoto; Hideki Ebihara; Kimihito Ito; Shigeru Morikawa; Heinz Feldmann; Ayato Takada
Journal:  J Virol Methods       Date:  2010-11-17       Impact factor: 2.014

Review 4.  New opportunities for field research on the pathogenesis and treatment of Lassa fever.

Authors:  Sheik Humarr Khan; Augustine Goba; May Chu; Cathy Roth; Tim Healing; Arthur Marx; Joseph Fair; Mary C Guttieri; Philip Ferro; Tiffany Imes; Corina Monagin; Robert F Garry; Daniel G Bausch
Journal:  Antiviral Res       Date:  2007-12-17       Impact factor: 5.970

5.  Assessment of the MSF triage system, separating patients into different wards pending Ebola virus laboratory confirmation, Kailahun, Sierra Leone, July to September 2014.

Authors:  Florian Vogt; Gabriel Fitzpatrick; Gabriela Patten; Rafael van den Bergh; Kathryn Stinson; Luigi Pandolfi; James Squire; Tom Decroo; Hilde Declerck; Michel Van Herp
Journal:  Euro Surveill       Date:  2015

6.  ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.

Authors:  Mara Jana Broadhurst; John Daniel Kelly; Ann Miller; Amanda Semper; Daniel Bailey; Elisabetta Groppelli; Andrew Simpson; Tim Brooks; Susan Hula; Wilfred Nyoni; Alhaji B Sankoh; Santigi Kanu; Alhaji Jalloh; Quy Ton; Nicholas Sarchet; Peter George; Mark D Perkins; Betsy Wonderly; Megan Murray; Nira R Pollock
Journal:  Lancet       Date:  2015-06-25       Impact factor: 79.321

7.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

8.  Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.

Authors:  P Formenty; C Hatz; B Le Guenno; A Stoll; P Rogenmoser; A Widmer
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone.

Authors:  Daniel J Park; Gytis Dudas; Shirlee Wohl; Augustine Goba; Shannon L M Whitmer; Kristian G Andersen; Rachel S Sealfon; Jason T Ladner; Jeffrey R Kugelman; Christian B Matranga; Sarah M Winnicki; James Qu; Stephen K Gire; Adrianne Gladden-Young; Simbirie Jalloh; Dolo Nosamiefan; Nathan L Yozwiak; Lina M Moses; Pan-Pan Jiang; Aaron E Lin; Stephen F Schaffner; Brian Bird; Jonathan Towner; Mambu Mamoh; Michael Gbakie; Lansana Kanneh; David Kargbo; James L B Massally; Fatima K Kamara; Edwin Konuwa; Josephine Sellu; Abdul A Jalloh; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Bobbie R Erickson; Tara Sealy; Dianna Blau; Christopher Paddock; Aaron Brault; Brian Amman; Jane Basile; Scott Bearden; Jessica Belser; Eric Bergeron; Shelley Campbell; Ayan Chakrabarti; Kimberly Dodd; Mike Flint; Aridth Gibbons; Christin Goodman; John Klena; Laura McMullan; Laura Morgan; Brandy Russell; Johanna Salzer; Angela Sanchez; David Wang; Irwin Jungreis; Christopher Tomkins-Tinch; Andrey Kislyuk; Michael F Lin; Sinead Chapman; Bronwyn MacInnis; Ashley Matthews; James Bochicchio; Lisa E Hensley; Jens H Kuhn; Chad Nusbaum; John S Schieffelin; Bruce W Birren; Marc Forget; Stuart T Nichol; Gustavo F Palacios; Daouda Ndiaye; Christian Happi; Sahr M Gevao; Mohamed A Vandi; Brima Kargbo; Edward C Holmes; Trevor Bedford; Andreas Gnirke; Ute Ströher; Andrew Rambaut; Robert F Garry; Pardis C Sabeti
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

10.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

View more
  18 in total

1.  New methodologies for the estimation of population vulnerability to diseases: a case study of Lassa fever and Ebola in Nigeria and Sierra Leone.

Authors:  Olumayowa Kajero; Victor Del Rio Vilas; James L N Wood; Giovanni Lo Iacono
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

2.  Investigating Outbreaks of Salmonella Typhimurium Using Case-Control Studies, with a Reference to the One Health Approach.

Authors:  Katrin Gaardbo Kuhn; Steen Ethelberg
Journal:  Methods Mol Biol       Date:  2021

3.  Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa.

Authors:  Saori Sakabe; Brian M Sullivan; Jessica N Hartnett; Refugio Robles-Sikisaka; Karthik Gangavarapu; Beatrice Cubitt; Brian C Ware; Dylan Kotliar; Luis M Branco; Augustine Goba; Mambu Momoh; John Demby Sandi; Lansana Kanneh; Donald S Grant; Robert F Garry; Kristian G Andersen; Juan Carlos de la Torre; Pardis C Sabeti; John S Schieffelin; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

4.  Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.

Authors:  C E Hulseberg; L Fénéant; K M Szymańska-de Wijs; N P Kessler; E A Nelson; C J Shoemaker; C S Schmaljohn; S J Polyak; J M White
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

5.  Virus genomes reveal factors that spread and sustained the Ebola epidemic.

Authors:  Gytis Dudas; Luiz Max Carvalho; Trevor Bedford; Andrew J Tatem; Guy Baele; Nuno R Faria; Daniel J Park; Jason T Ladner; Armando Arias; Danny Asogun; Filip Bielejec; Sarah L Caddy; Matthew Cotten; Jonathan D'Ambrozio; Simon Dellicour; Antonino Di Caro; Joseph W Diclaro; Sophie Duraffour; Michael J Elmore; Lawrence S Fakoli; Ousmane Faye; Merle L Gilbert; Sahr M Gevao; Stephen Gire; Adrianne Gladden-Young; Andreas Gnirke; Augustine Goba; Donald S Grant; Bart L Haagmans; Julian A Hiscox; Umaru Jah; Jeffrey R Kugelman; Di Liu; Jia Lu; Christine M Malboeuf; Suzanne Mate; David A Matthews; Christian B Matranga; Luke W Meredith; James Qu; Joshua Quick; Suzan D Pas; My V T Phan; Georgios Pollakis; Chantal B Reusken; Mariano Sanchez-Lockhart; Stephen F Schaffner; John S Schieffelin; Rachel S Sealfon; Etienne Simon-Loriere; Saskia L Smits; Kilian Stoecker; Lucy Thorne; Ekaete Alice Tobin; Mohamed A Vandi; Simon J Watson; Kendra West; Shannon Whitmer; Michael R Wiley; Sarah M Winnicki; Shirlee Wohl; Roman Wölfel; Nathan L Yozwiak; Kristian G Andersen; Sylvia O Blyden; Fatorma Bolay; Miles W Carroll; Bernice Dahn; Boubacar Diallo; Pierre Formenty; Christophe Fraser; George F Gao; Robert F Garry; Ian Goodfellow; Stephan Günther; Christian T Happi; Edward C Holmes; Brima Kargbo; Sakoba Keïta; Paul Kellam; Marion P G Koopmans; Jens H Kuhn; Nicholas J Loman; N'Faly Magassouba; Dhamari Naidoo; Stuart T Nichol; Tolbert Nyenswah; Gustavo Palacios; Oliver G Pybus; Pardis C Sabeti; Amadou Sall; Ute Ströher; Isatta Wurie; Marc A Suchard; Philippe Lemey; Andrew Rambaut
Journal:  Nature       Date:  2017-04-12       Impact factor: 49.962

6.  Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever.

Authors:  Tiago Abreu-Mota; Katie R Hagen; Kurt Cooper; Peter B Jahrling; Gene Tan; Christoph Wirblich; Reed F Johnson; Matthias J Schnell
Journal:  Nat Commun       Date:  2018-10-11       Impact factor: 14.919

Review 7.  Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.

Authors:  Nicholas Israel Nii-Trebi
Journal:  Biomed Res Int       Date:  2017-02-13       Impact factor: 3.411

8.  Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection.

Authors:  Emily Speranza; Ignacio Caballero; Anna N Honko; Joshua C Johnson; J Kyle Bohannon; Lisa Evans DeWald; Dawn M Gerhardt; Jennifer Sword; Lisa E Hensley; Richard S Bennett; John H Connor
Journal:  mBio       Date:  2020-06-16       Impact factor: 7.867

9.  Infection Rates and Risk Factors for Infection Among Health Workers During Ebola and Marburg Virus Outbreaks: A Systematic Review.

Authors:  Saranya A Selvaraj; Karen E Lee; Mason Harrell; Ivan Ivanov; Benedetta Allegranzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

10.  A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.

Authors:  William R Gallaher
Journal:  Arch Virol       Date:  2020-07-31       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.